MYCN and neuroblastoma: NB is a complex and heterogeneous disease, with conventional risk stratification factors depending of the patient age, histological category, MYCN oncogene status, DNA ploidy, and specific segmental chromosomal aberrations, all of which demonstrate a strong correlation with molecular signatures in NB [3].